KR940002223A - 특정 1,4-디히드로 피리딘-3,5-디카르 복실산 에스테르, 그의 제조 방법 및 그의 제약학적 용도 - Google Patents
특정 1,4-디히드로 피리딘-3,5-디카르 복실산 에스테르, 그의 제조 방법 및 그의 제약학적 용도 Download PDFInfo
- Publication number
- KR940002223A KR940002223A KR1019930013536A KR930013536A KR940002223A KR 940002223 A KR940002223 A KR 940002223A KR 1019930013536 A KR1019930013536 A KR 1019930013536A KR 930013536 A KR930013536 A KR 930013536A KR 940002223 A KR940002223 A KR 940002223A
- Authority
- KR
- South Korea
- Prior art keywords
- chloro
- dimethyl
- compound
- preparation
- general formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
Abstract
본 발명은 신규한 디메틸 4-(4-클로로-3-트리플루오로메틸페닐)-1-시클로프로필-2,6-디메틸-1,4-디히드로피리딘-3,5-디카르복실레이트, 그의 제조 방법 및 미세순환 장애에 연루한 허혈성 질환 치료용 의약으로서의 그의 용도에 관한 것이다. 이러한 작용은 말초 혈관계 및 뇌 혈관계 양자에 공히 가능하다. 본 발명의 화합물은 강력한 혈류 촉진 작용을 가지고 순환계, 특히 미세순환계를 개선하며 혈압에는 영향을 끼치지 않은 특징이 있다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (5)
- 디메틸 4-(4-클로로-3-트리플루오로메틸페닐)-1-시클로프로필-2,6-디메틸-1,4-디히드로피리딘-3,5-디카르복실레이트.
- [A] 하기 일반식(Ⅱ)의 메틸 4-(4-클로로-3-트리플루오로메틸벤질리덴)아세토아세테이트를 불활성 용매중에서, 또는 용매없이 적절한 경우, 염기/산의 존재하에 메틸 3-시클로프로필아미노크로토네이트와 직접 반응시키거나, 또는 메틸 아세토아세테이트 및 시클로프로필아민 염산염과 반응시키거나 또는, [B] 하기 일반식(Ⅲ)의 4-클로로-3-트리플루오로메틸벤즈알데히드를 피리딘 중에서, 메틸 아세토아세테이트 및 시클로프로필아민 염산염과 반응시키거나, 또는 시클로프로필아민 및 피리딘 염과 각각 반응시키거나, 또는, [C] 우선 보호기체 분위기 하에 루이스만, 바람직하게는 사염화티타늄을 염기, 바람직하게는 피페리딘을 사용하여 불활성 용매 중의 메틸 3-시클로프로필아미노크로토네이트로 처리하고, 이어서 일반식(Ⅲ)이 4-클로로-3-트리플루오로메틸벤즈알데히드를 가하는 것을 특징으로 하는 디메틸 4-(4-클로로-3-트리플루오로메틸페닐)-1-시클로프로필-2,6-디메틸-1,4-디히드로피리딘-3,5-디카르복실레이트의 제조방법.
- 제1항의 화합물을 함유하는 의약.
- 제1항의 화합물을, 적절한 경우 통상적인 보조제 및 부형제를 가하여 적합한 투여 형태로 전환시키는 것을 특징으로 하는 제조 방법.
- 미세순환 장애의 치료를 위한 제1항의 화합물의 용도.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7/916,916 | 1992-07-20 | ||
DE4223867A DE4223867A1 (de) | 1992-07-20 | 1992-07-20 | Spezieller 1,4-Dihydropyridin-3,5-dicarbonsäureester, Verfahren zu seiner Herstellung und seine pharmazeutische Verwendung |
USP4223867.6 | 1992-07-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR940002223A true KR940002223A (ko) | 1994-02-16 |
Family
ID=6463655
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019930013536A KR940002223A (ko) | 1992-07-20 | 1993-07-19 | 특정 1,4-디히드로 피리딘-3,5-디카르 복실산 에스테르, 그의 제조 방법 및 그의 제약학적 용도 |
Country Status (16)
Country | Link |
---|---|
US (1) | US5559139A (ko) |
EP (1) | EP0581079A1 (ko) |
JP (1) | JPH06179654A (ko) |
KR (1) | KR940002223A (ko) |
CN (1) | CN1085548A (ko) |
AU (1) | AU4164693A (ko) |
CA (1) | CA2100707A1 (ko) |
CZ (1) | CZ141593A3 (ko) |
DE (1) | DE4223867A1 (ko) |
FI (1) | FI933255A (ko) |
HU (1) | HU9302077D0 (ko) |
IL (1) | IL106369A0 (ko) |
MX (1) | MX9304119A (ko) |
PL (1) | PL299713A1 (ko) |
SK (1) | SK76293A3 (ko) |
ZA (1) | ZA935191B (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103044316A (zh) * | 2013-01-23 | 2013-04-17 | 石家庄学院 | 一种以咪唑离子液体为催化剂制备1,4-二氢吡啶的方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3883543A (en) * | 1969-05-10 | 1975-05-13 | Bayer Ag | N-alkyl-1,4-dihydropyridines |
DE1923990C3 (de) * | 1969-05-10 | 1978-11-23 | Bayer Ag | Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern |
DE2210667A1 (de) * | 1972-03-06 | 1973-09-20 | Bayer Ag | Kondensiert aromatisch substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
US3956341A (en) * | 1974-02-21 | 1976-05-11 | Smithkline Corporation | 1,3,5-Tricarbo-1,4-dihydropyridines |
US4975440A (en) * | 1984-09-28 | 1990-12-04 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Optically-active 1,4-dihydropyridine |
US4780538A (en) * | 1986-02-12 | 1988-10-25 | Merck & Co., Inc. | Process for 1,4-dihydropyridine compounds using a titanamine catalyst |
DE4011695A1 (de) * | 1990-04-11 | 1991-10-17 | Bayer Ag | Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsaeureestern als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung |
DE4200714A1 (de) * | 1992-01-14 | 1993-07-15 | Bayer Ag | Spezieller 1,4-dihydropyridin-3,5-dicarbonsaeureester, verfahren zu seiner herstellung und seine pharmazeutische verwendung |
-
1992
- 1992-07-20 DE DE4223867A patent/DE4223867A1/de not_active Withdrawn
-
1993
- 1993-06-30 AU AU41646/93A patent/AU4164693A/en not_active Abandoned
- 1993-07-08 EP EP93110936A patent/EP0581079A1/de not_active Ceased
- 1993-07-08 MX MX9304119A patent/MX9304119A/es unknown
- 1993-07-13 US US08/090,722 patent/US5559139A/en not_active Expired - Fee Related
- 1993-07-15 CZ CZ931415A patent/CZ141593A3/cs unknown
- 1993-07-16 PL PL93299713A patent/PL299713A1/xx unknown
- 1993-07-16 IL IL106369A patent/IL106369A0/xx unknown
- 1993-07-16 FI FI933255A patent/FI933255A/fi not_active Application Discontinuation
- 1993-07-16 CA CA002100707A patent/CA2100707A1/en not_active Abandoned
- 1993-07-19 ZA ZA935191A patent/ZA935191B/xx unknown
- 1993-07-19 JP JP5198759A patent/JPH06179654A/ja active Pending
- 1993-07-19 KR KR1019930013536A patent/KR940002223A/ko not_active Application Discontinuation
- 1993-07-19 SK SK762-93A patent/SK76293A3/sk unknown
- 1993-07-19 HU HU9302077A patent/HU9302077D0/hu unknown
- 1993-07-20 CN CN93108711A patent/CN1085548A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
MX9304119A (es) | 1994-02-28 |
US5559139A (en) | 1996-09-24 |
ZA935191B (en) | 1994-03-02 |
FI933255A (fi) | 1994-01-21 |
CZ141593A3 (en) | 1994-03-16 |
PL299713A1 (en) | 1994-03-21 |
DE4223867A1 (de) | 1994-01-27 |
CA2100707A1 (en) | 1994-01-21 |
JPH06179654A (ja) | 1994-06-28 |
CN1085548A (zh) | 1994-04-20 |
AU4164693A (en) | 1994-01-27 |
EP0581079A1 (de) | 1994-02-02 |
IL106369A0 (en) | 1993-11-15 |
FI933255A0 (fi) | 1993-07-16 |
SK76293A3 (en) | 1994-07-06 |
HU9302077D0 (en) | 1993-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU93054168A (ru) | Димер молекулярного варианта аро-липопротеина, способ его получения, фармацевтическая композиция на его основе | |
ATE275546T1 (de) | N-substituierte cycloalkyl- und polycycloalkyl- alpha-substituierte trp-phe- und phenethylaminderivate | |
ATE63220T1 (de) | Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben. | |
MC2279A1 (fr) | Nouveaux pyrroles substitues,utiles comme medicaments,leur procede de preparation et medicament les contenant | |
KR910018025A (ko) | 약제로서 n-알킬화 1,4-디히드로피리딘디카르복실산 에스테르의 용도, 신규 화합물-및 그의 제조방법 | |
RU92016595A (ru) | Замещенные тиазолильные и замещенные пиридинильные производные, фармацевтическая композиция и способ их получения | |
DE68923169T2 (de) | Verwendung von fluor enthaltenden Pyridoncarbonsäure-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von HIV infektionen. | |
KR900018027A (ko) | 피페리딘 유도체, 그의 제조 방법, 및 그것을 유효성분으로 함유하는 의약용 조성물 | |
KR940002223A (ko) | 특정 1,4-디히드로 피리딘-3,5-디카르 복실산 에스테르, 그의 제조 방법 및 그의 제약학적 용도 | |
KR870004022A (ko) | 플라본 유도체의 제조방법 | |
ATE55248T1 (de) | Arzneimittelkombination. | |
KR930002316A (ko) | N-알킬화 1,4-디하이드로피리 딘디카르복실산 에스테르 | |
DE69020199D1 (de) | Durch Azetidine substituierte Derivate von Pyridon-Carboxylsäure, ihre Herstellung und Verwendung als Arzneimittel. | |
KR930016399A (ko) | 특정 1,4-디히드로피리딘-3,5-디카르복실산 에스테르, 그의 제조 방법 및 그의 제약 용도 | |
FR2613617B1 (fr) | Agents medicamenteux pour la prevention et la therapie des brulures cutanees par rayons, contenant comme principe actif la 2,6-dimethyl-3,5-diethoxycarbonyl-1,4-dihydropyridine | |
KR910019974A (ko) | 치환된 인돌 | |
EP0760367A3 (de) | Verfahren zur Herstellung von 4-Acylamino-2,2,6,6-tetramethylpiperidinen | |
KR920002597A (ko) | 3-[(5-메틸-2-푸라닐) 메틸]-N-(4-피페리디닐)-3H-이미다조[4,5-b]-피리딘-2-아민 2-하이드록시-1, 2, 3-프로판트리카르복실레이트 | |
RU2005119970A (ru) | Оптически активное производное дигидропиридина | |
EP0244595A3 (de) | Dihydropyridinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
KR940021524A (ko) | 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법 | |
RU93005013A (ru) | 1-аминоспиро[изохинолин-4(1н)3-пирролидин-1,2,3,5'(2н)-тетроны] и их аналоги, способ их получения и фармацевтическая композиция | |
KR900011757A (ko) | 피리디늄 니트레이트, 그의 제조방법 및 용도 | |
Bossert | The chemistry of nifedipine | |
DZ1831A1 (fr) | Isopropyl 2-méthoxyéthyl 4-(2-chloro-3-cyano-phényl)-1,4-dihydro 2,6-diméthyl-pyridine 3,5-dicarboxylate. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |